Literature DB >> 8549327

Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.

K Vogt1, H Hahn, J Hermann, U F Haustein, U Blume, H Gollnick, C E Orfanos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549327     DOI: 10.2165/00003495-199500492-00065

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  The microbial colonization of inflamed acne vulgaris lesions.

Authors:  J P Leeming; K T Holland; W J Cuncliffe
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

2.  Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.

Authors:  E A Eady; J H Cove; K T Holland; W J Cunliffe
Journal:  Br J Dermatol       Date:  1989-07       Impact factor: 9.302

  2 in total
  4 in total

1.  Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.

Authors:  M Takei; H Fukuda; R Kishii; M Hosaka
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 2.  Topical antibacterial therapy for acne vulgaris.

Authors:  Brigitte Dreno
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Transdermal penetration of topical drugs used in the treatment of acne.

Authors:  Andrea Krautheim; Harald Gollnick
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study.

Authors:  Bela Jaswantlal Shah; Tharayil Kunneth Sumathy; Rachita Savalaram Dhurat; Raghunandan Govind Torsekar; Vishalakshi Viswanath; Jayesh Ishwardas Mukhi; Ganesh Kadhe; Pashmina Ahirrao
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.